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Abstract 
Background: Microbial biorefinery approaches are beginning to define renewable and sustainable routes to clean-
burning and non-fossil fuel-derived gaseous alkanes (known as ‘bio-LPG’). The most promising strategies have used a 
terminal fatty acid photodecarboxylase, enabling light-driven propane production from externally fed waste butyric 
acid. Use of Halomonas (a robust extremophile microbial chassis) with these pathways has enabled bio-LPG produc-
tion under non-sterile conditions and using waste biomass as the carbon source. Here, we describe new engineering 
approaches to produce next-generation pathways that use amino acids as fuel precursors for bio-LPG production 
(propane, butane and isobutane blends).
Results: Multiple pathways from the amino acids valine, leucine and isoleucine were designed in E. coli for the 
production of propane, isobutane and butane, respectively. A branched-chain keto acid decarboxylase-dependent 
pathway utilising fatty acid photodecarboxylase was the most effective route, generating higher alkane gas titres over 
alternative routes requiring coenzyme A and/or aldehyde deformylating oxygenase. Isobutane was the major gas 
produced in standard (mixed amino acid) medium, however valine supplementation led to primarily propane pro-
duction. Transitioning pathways into Halomonas strain TQ10 enabled fermentative production of mixed alkane gases 
under non-sterile conditions on simple carbon sources. Chromosomal integration of inducible (~ 180 mg/g cells/day) 
and constitutive (~ 30 mg/g cells/day) pathways into Halomonas generated production strains shown to be stable for 
up to 7 days.
Conclusions: This study highlights new microbial pathways for the production of clean-burning bio-LPG fuels from 
amino acids. The use of stable Halomonas production strains could lead to gas production in the field under non-
sterile conditions following process optimisation.
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Background
Global concerns about dwindling fossil fuel supplies 
have led to an urgent need to transition towards more 
sustainable bio-economy strategies [1]. This includes 
implementing economically viable routes to sustainable 
clean-burning biofuels derived from renewable waste 
biomass or industrial waste streams with minimal down-
stream processing costs. Microbial strategies for gaseous 
bio-alkane production (propane and butane) are prom-
ising because of the existence of well-established global 
markets (20 million tonnes propane per annum) and 
fuels distribution infrastructures [2]. The ‘drop-in’ nature 
of propane can boost the calorific value of existing biogas 
supplies, and propane has lower energy requirements for 
liquefaction and/or transportation [2]. In addition, the 
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hydrocarbon blends (propane, butane and isobutane) for 
use as propellants [3].
Engineered microbial routes to bio-propane and other 
gaseous hydrocarbons are now well established [4–9]. 
These pathways are dependent on variant forms of either 
aldehyde deformylating oxygenase (ADO) from Prochlo-
rococcus marinus [4–6, 9, 10] or fatty acid photodecar-
boxylase (CvFAP) from Chlorella variabilis [4, 8, 11]. 
ADO variant A134F catalyses the NADPH-dependent 
decarbonylation of butyraldehyde to propane in the pres-
ence of its electron transfer partner ferredoxin [4, 6, 12]. 
CvFAP variants G462I and G462V were shown to cata-
lyse the blue light-dependent decarboxylation of butyric 
and valeric acids to propane and butane, respectively 
[4]. In the latter case, microbial alkane production can 
be achieved in vivo by direct feeding of volatile fatty acid 
(VFA) precursor molecules. Alternative routes require 
the upregulation of butyraldehyde or butyric acid, uti-
lising pathways derived from fatty acid biosynthesis [5], 
reverse β-oxidation [7], valine biosynthesis [9] or the 
clostridial butanol pathway [6].
We recently explored the commercial potential of 
CvFAP-dependent bio-LPG production (bio-propane/
butane blends) using recombinant E. coli, Halomonas 
and Synechocystis as microbial chassis [4]. Amino acids 
were explored as potential bio-alkane precursors, where 
valine (C3), isoleucine (n-C4) and leucine (i-C4) could 
be converted to propane, butane and isobutane, respec-
tively (Fig.  1). In these pathways, amino acids undergo 
deamination by leucine 2-oxoglutarate transaminase 
(ilvE; [13]) to generate α-keto acids, followed by the 
action of branched-chain keto acid decarboxylase (KdcA; 
[14]) to generate the respective aldehyde. The action of 
the aldehyde dehydrogenase 3-hydroxypropionaldehyde 
dehydrogenase (Hpad; [15]) produced the equivalent car-
boxylic acid, which underwent decarboxylation to bio-
alkane gas by  CvFAPG462I (Fig. 1). This KdcA-dependent 
route successfully produced bio-LPG blends in both E. 
coli and Halomonas, using proteinaceous waste as the 
source of amino acids [4].
In this study, we have explored the potential of addi-
tional CvFAP- and ADO-dependent routes to gaseous 
bio-alkanes from the amino acids valine, isoleucine and 
leucine. A second coenzyme A (CoA)-dependent [16] 
route was designed (Fig. 1; Additional file 1: Figs. S1, S2), 
and the original KdcA-dependent route was refactored to 
identify the optimal aldehyde dehydrogenase homologue 
and promoter system. Optimised pathways were incor-
porated into E. coli and the industrial chassis Halomonas 
either on plasmids or as stable chromosomally inte-
grated strains. Fermentative production of gaseous bio-
alkanes was achieved, demonstrating the potential of this 
approach for bio-LPG production. This study illustrates 
a potentially viable alternative to the VFA-fed CvFAP-
dependent bio-alkane route for commercial exploitation, 
as food waste could act as both the bio-alkane precursor 
and carbon source, eliminating the need to supplement 
cultures with potentially cytotoxic VFAs.
Results and discussion
CoA‑dependent pathway design from amino acids 
to bio‑alkanes
A CoA-dependent (VFA-producing) pathway with 
CvFAP was designed, based on the ADO-dependent 
clostridial butanol pathway from butyryl-CoA to propane 
[6]. Similar to the KdcA pathway, an initial ilvE-depend-
ent amino acid deamination generates the respective 
α-keto acids (Fig.  1). This is followed by CoA-depend-
ent decarboxylation of the α-keto acid, catalysed by the 
human branched-chain α-keto acid dehydrogenase com-
plex (BCKDHAB) [16]. CoA is subsequently eliminated 
by acyl-CoA thioester hydrolase (YciA; Haemophilus 
influenza) [6] to generate the respective carboxylic acid 
(Fig. 1). This is similar to the native leucine to isovaleric 
acid route described in Propionibacterium freudenreichii 
[17]. Finally, decarboxylative alkane production is cata-
lysed by the G462V or G462I variant of CvFAP.
To generate the ADO-dependent pathway version, the 
carboxylic acid precursor is converted into the respective 
aldehyde by carboxylic acid reductase (CAR; Mycobacte-
rium marinum) activated by the maturation factor phos-
phopantetheinyl transferase (sfp; Bacillus subtilis) [6]. 
The terminal step is the ADO- and ferredoxin-dependent 
decarbonylation of the aldehydes to bio-alkanes (Fig. 1). 
All of the enzymes in this pathway were shown to express 
in E. coli in an active form (Additional file 1: Figs. S3, S4; 
[4, 6]). An alternative CoA-dependent route from threo-
nine to butane was also designed (Additional file 1: Figs. 
S2–S4), with the initial ilvE step substituted for threo-
nine dehydratase (ilvA) from E. coli [18] and hydrocar-
bon chain extension performed by the E. coli leuABCD 
operon [19]. However initial constructs did not produce 
detectable propane due to the absence of activity of the 
LeuABCD-catalysed steps (results not shown). Therefore, 
the threonine-to-butane pathway was not investigated 
further in this study.
CoA‑dependent pathway bio‑alkane gas production
To test the performance of in vivo bio-alkane production 
from amino acids, a series of five ADO-dependent DNA 
expression constructs were assembled in E. coli (AFY-
SCIB;  ADOA134F-Ferr-YciA-sfp-CAR-ilvE-BCKDHAB). 
These constructs varied by the presence of either one or 
two isopropyl β-d-thiogalactopyranoside (IPTG)-induc-
ible (trc) or constitutive promoters (proD or trcΔlac) 
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[20] located upstream of the ilvE and/or  ADOA134F 
genes (Fig.  2a inset). The constitutive promoter trcΔlac 
was generated by removing the repressor protein gene 
(lacI) and the operator region from a standard trc pro-
moter. Initial in vivo trials were performed with the sin-
gle proD-controlled construct, expressed in multiple E. 
coli strains. Highest gaseous bio-alkane production was 
observed in the double deletion strain BL21(DE3)ΔΔ [4, 
5], with propane making up to 79% of the total hydro-
carbon gas in the culture headspace (0.11 ± 0.01  mg/L 
propane; Additional file  1: Fig. S5 and Table  S1). This 
strain was designed previously to reduce the competing 
pathway from butyraldehyde to butanol by knocking out 
the E. coli aldehyde reductases Ahr and YqhD [5]. It has 
been shown to increase in  vivo propane titres in ADO-
dependent pathways [5, 6], so was selected as the E. coli 
chassis for the remainder of this work.
In vivo alkane production by five AFYSCIB constructs 
in E. coli showed the highest bio-alkane titres when only 
one promoter (trc or proD) was present upstream of 
 ADOA134F (Fig.  2a; Additional file  1: Table  S2). The sin-
gle trc–containing construct showed a 21-fold increase 
in propane titres over the equivalent proD-containing 
version. The best performing construct contained a sin-
gle trcΔlac promoter (0.96 ± 0.01  mg propane/L cul-
ture), with yields similar to those obtained with the 
 ADOA134F-dependent clostridial butanol pathway from 
glucose (3.4 mg/L [6]). Low levels of butane and/or isob-
utane were also detected with the single promoter con-
structs, with levels up to 10% of the total alkanes (up 
to 0.02 ± 0.01  mg butane/L culture; Fig.  2a). These data 
show that the CoA-dependent route can successfully 
generate low levels of multiple gaseous alkanes under 
standard E. coli cultivation conditions in the absence of 
Fig. 1 Overall scheme of the biocatalytic production of gaseous hydrocarbons propane, isobutane and butane from amino acids valine, leucine 
and isoleucine, respectively. Enzymes: ilvE = leucine 2-oxoglutarate transaminase from E. coli; BCKDHAB = human branched-chain α-keto acid 
dehydrogenase complex; YciA = acyl-CoA thioester hydrolase from Haemophilus influenza; CAR = carboxylic acid reductase from Mycobacterium 
marinum; sfp = maturation factor phosphopantetheinyl transferase from Bacillus subtilis; CvFAP = fatty acid photodecarboxylase from Chlorella 
variabilis; ADO = aldehyde deformylating oxygenase from Prochlorococcus marinus; Ferr = ferredoxin from Synechocystis sp. PCC6803 and 
KdcA = branched-chain keto acid decarboxylase from Lactococcus lactis. AlDH enzymes: αKGSDH = α-ketoglutaric semialdehyde dehydrogenase 
from Burkholderia ambifaria; PadA = phenylacetaldehyde dehydrogenase 17 from E. coli; or Hpad = 3-hydroxypropionaldehyde dehydrogenase 
puuC from E. coli 
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additional amino acid supplementation. However, a prior 
study showed an ADO-dependent reverse-β-oxidation 
biosynthesis pathway from glycerol generated ca 22-fold 
higher butane titres (0.46 mg/L [7]).
Additional CoA-dependent pathways to bio-alkanes 
were designed to simplify the pathway and substitute 
the catalytically slow ADO enzyme [12] for the light-
dependent  CvFAPG462V variant enzyme [4]. This latter 
enzyme has a reported reaction quantum yield of greater 
than 80% [8]. Pathway modification required the elimina-
tion of the two terminal steps catalysed by CAR/sfp and 
 ADOA134F/Ferr, as CvFAP directly acts on the carboxylic 
acid precursor (Fig. 1). This shortened pathway may have 
the added advantage of a lower overall cellular burden in 
E. coli as fewer recombinant genes are expressed.
We generated two CvFAP-dependent constructs 
 (FG462VYIB; CvFAP-YciA-ilvE-BCKDHAB; Fig.  2b inset), 
which differed by the type of promoter upstream of 
 CvFAPG462V (trc or proD). Gaseous alkane production 
was seen in E. coli only in the trc-containing construct in 
the presence of blue light, at titres similar to those seen 
with the best AFYSCIB pathway (0.98 ± 0.06  mg/L cul-
ture; Fig.  2b; Additional file  1: Table  S2). Propane titres 
were at least tenfold higher than butane or isobutane, 
which differs from the CvFAP-dependent KdcA route [4] 
where the dominant gas produced was isobutane (4.8-
fold higher than propane). This is likely due to substrate 
preferences of KdcA and/or differences in the amino acid 
concentrations present in the culture medium [21].
The requirement for blue light in CvFAP-dependent 
pathways necessitates adaptations to traditional in  vivo 
bacterial cultivation strategies, as prolonged exposure to 
blue light (380–500 nm) is known to decrease the viability 
of E. coli [22] and cause the photoinactivation of CvFAP 
[4, 23]. Therefore, dark cycles (light absence) might be 
required periodically during fermentation to ensure the 
maintenance of sufficient cell density and the regenera-
tion of biocatalysts. As ADO-dependent pathways do 
not require light, we tested E. coli strains expressing 
 CvFAPG462V with AFYSCIB pathways for alkane gas pro-
duction (Fig. 2b inset). However, in each case bio-alkane 
gas production was lower than what was obtained with 
the individual pathways alone (0.15–0.26  mg propane/L 
culture; Fig.  2b; Additional file  1: Table  S2). This could 
potentially be due to the additional cellular burden of 
extra gene overexpression and/or the requirement of two 
antibiotics to maintain both plasmids.
Overall, we have demonstrated gaseous alkane produc-
tion in E. coli using the CoA-dependent routes, although 
the levels are at best ~ 6.5-fold lower than the KdcA-
dependent route with CvFAP [4]. Therefore, we focused 
our studies on improving the KdcA-dependent pathway, 
which utilises CvFAP in place of ADO. This route shows 
more promise as a potential industrially useful route to 
gaseous bio-alkanes from amino acids.
KdcA‑dependent route refactoring
The existing KdcA-dependent pathway (Fig. 1) is a four-
gene construct  (IHKFG462I; ilvE-Hpad-KdcA-CvFAP [4]) 
controlled by two trc promoters upstream of ilvE and 
KdcA. We targeted the aldehyde dehydrogenase (AlDH) 
Fig. 2 Hydrocarbon production of E. coli strain BL21(DE3)∆∆ 
containing engineered a ADO- and b CvFAP-dependant routes. 
Cultures (10 mL) were grown in LB medium containing 30 μg/
mL kanamycin and 50 µg/mL chloramphenicol (pTrF/TrADO and 
pPrF/TrADO only) for 4–6 h at 37 °C and 180 rpm. Protein induction 
(100 μM IPTG) was performed for trc-containing constructs, and 
triplicate aliquots (1 mL) each of 3 biological replicate cultures 
were sealed into glass vials (3 mL) at 30 °C for 16–18 h at 200 rpm. 
For CvFAP-dependent constructs, the cultures were illuminated 
continuously with a blue LED (455 nm or 470 nm). Gaseous 
hydrocarbon levels were determined by manual headspace 
injection on an Agilent 490 Micro GC. Errors represent one standard 
deviation of the replicates (biological and/or technical triplicates). 
Constructs (inset): ProD = pPrAFYSCIB; ProD/ProD = pPrAFYSCPrIB; 
Trc = pTrAFYSCIB; Trc/Trc = pTrAFYSCTrIB and Trc-lacIq = pTrΔLAFYSCIB
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and terminal decarboxylation (CvFAP) steps in this path-
way to see if further improvements in bio-alkane yields 
could be obtained. The existing AlDH is 3-hydroxypro-
pionaldehyde dehydrogenase (Hpad) from E. coli, which 
have known activity towards isovaleraldehyde, butyral-
dehyde and valeraldehyde [15]. Two alternative aldehyde 
dehydrogenase homologues were selected, based on their 
known substrate specificities for short chain aldehydes. 
The first was α-ketoglutaric semialdehyde dehydrogenase 
(αKGSDH) from Azospirillum brasilense as it displays a 
known broad specificity [24]. The second homologue is 
phenylacetaldehyde dehydrogenase 17 (PadA) from E. 
coli, which is involved in phenylalanine degradation [25]. 
Each of these AlDH genes expressed in soluble active 
form in E. coli (Additional file 1: Figures S3, S4). In addi-
tion, both G462I and G462V variants of CvFAP were 
incorporated to see which supports the highest levels of 
bio-alkane gas production in vivo.
Six KdcA-dependent pathways were constructed under 
trc control, differing by the AlDH homologue and the 
specific CvFAP variant (Fig. 3a inset). A shortened ADO-
dependent version of this pathway (IKAF; ilvE-KdcA-
ADOA134F-Ferr; Fig. 1) was not investigated in this study 
as prior studies suggested a CvFAP-dependent route is 
likely to be more productive [4]. For example, the CvFAP 
route is much more redox efficient as ADO needs a lot 
of cofactor, whereas CvFAP uses light for activation. In 
the CvFAP-dependent version the conversion of aldehyde 
back to acid by Hpad or homologues should also generate 
a reduced cofactor.
As expected, dramatically higher titres of gaseous bio-
alkanes were detected in all six KdcA-dependent path-
ways compared to the CoA-dependent routes (Fig.  3a; 
Additional file  1: Table  S2). In each case, the major gas 
produced was isobutane (73–79% total bio-alkane), with 
propane proportions decreased to only 12–18% of the 
total headspace alkane. In addition, there was a 2- to 
2.4-fold increase in isobutane titres with CvFAP variant 
G462I over G462V [4]. There was a slight improvement 
in bio-alkane production with Hpad, consistent with its 
known specificity for isovaleraldehyde, butyraldehyde 
and valeraldehyde [15]. The highest bio-alkane-yielding 
construct generated isobutane titres of 48.7 ± 3.2  mg/L 
in standard E. coli growth medium. This is comparable to 
E. coli expressing  CvFAPG462I alone supplemented with 
isovaleric acid (87  mg/L culture; [4]). Production levels 
were also dependent on the plasmid backbone, as chang-
ing from a kanamycin-resistant to an ampicillin-resistant 
construct showed significant decreases in alkane titres 
(Additional file 1: Table S3).
The ratio of gases produced was similar in 
each KdcA-dependent pathway version, with 
isobutane:propane:butane ratios of ca 76:12:12 for the 
Fig. 3 Hydrocarbons production of E. coli strain BL21(DE3)∆∆ 
containing engineered KdcA/CvFAPG462V-dependent routes. 
Gaseous alkane yields dependent on the a enzyme homologues 
and b amino acid supplementation for pTrIHTrKFG462I construct. 
Cultures (10–20 mL) were grown in LB medium containing 30 μg/
mL kanamycin for 4–6 h at 37 °C and 180 rpm. Luria broth contains 
ca 7, 8.8 and 5.4 mM valine, isoleucine and leucine, respectively 
[21]. Protein induction (100 μM IPTG) was performed, followed by 
culture supplementation with valine, leucine or isoleucine (30 mg/
mL) in part B) after 1 h at 30 °C. Triplicate samples (1 mL) each of 3 
biological replicate cultures were sealed into glass vials (4 mL) and 
incubated at 30 °C for 16–18 h at 200 rpm, illuminated continuously 
with a blue LED (455 nm or 470 nm). Gaseous hydrocarbon 
levels were determined by manual headspace injection on an 
Agilent 490 Micro GC. Errors represent one standard deviation 
of the replicates (biological and/or technical triplicates). Data for 
LB + valine was obtained from previous studies [4]. Expression 
constructs (inset): αKGSDH/V = trc-ilvE-αKGSDH-trc-kdcA-CvFAPG462V; 
Hpad/V = trc-ilvE-Hpad-trc-kdcA-CvFAPG462V; 
PadA/V = trc-PadA-Hpad-trc-kdcA-CvFAPG462V; 
αKGSDH/I = trc-ilvE-αKGSDH-trc-kdcA-CvFAPG462I; 
Hpad/I = trc-ilvE-Hpad-trc-kdcA-CvFAPG462I and PadA/I = trc-PadA-Hp
ad-trc-kdcA-CvFAPG462I
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highest producing construct. This switch from predomi-
nantly propane to isobutane production suggests that 
KdcA may have a higher preference for α-ketoisocaproate 
over α-ketoisovalerate or α-keto-β-methylvalerate (Addi-
tional file 1: Figs. S1, S2). As each AlDH-containing con-
struct generated similar ratios of each bio-alkane gas, the 
product profile might in part be influenced by the amino 
acid composition of the medium and their relative uptake 
rates into the cell.
Tuneable bio‑alkane blends
Ideally, a route to bio-LPG based on microbial fermen-
tation would be tuneable, to allow precise control of the 
relative ratios of propane:butane (± isobutane) to suit 
customer requirements. This was demonstrated success-
fully in E. coli expressing only CvFAP variants, where 
propane-to-butane ratios were dependent on the rela-
tive proportions of butyric and valeric acids fed to the 
cultures, respectively [4]. A similar system could be 
applied using the KdcA-dependent pathway by supple-
menting the culture with specific amino acid blends. This 
approach could be a suitable alternative to VFA feeding 
as amino acid supplementation does not have the pH and 
cytotoxicity effects seen when adding millimolar concen-
trations of organic acids to cultures. In addition, a local-
ised anaerobic digestion plant [4] would not be required 
to generate VFAs from waste biomaterial.
Leucine and isoleucine supplementation of E. coli 
cultures expressing  IHKFG462I showed proportional 
increases in isobutane and butane, respectively, with-
out reaching saturation levels (Fig.  3b; Additional file 1: 
Fig. S6 and Table  S4). These data are similar to previ-
ous studies with valine supplementation, where increas-
ing levels of propane were generated [4]. With 30  mg/
mL individual amino acid supplementation, similar 
yields of propane, isobutane and butane were detected 
(110 ± 6 [4], 112 ± 0.6 and 142 ± 3  mg/L, respectively). 
In each case, the predominant gas was greater than 95% 
of the total headspace alkane produced. Therefore, the 
desired country- or customer-specific requirements for 
propane:butane:isobutane ratios (bio-LPG or aerosol 
propellants [3]) during alkane gas production could be 
achieved by enriching the culture medium with specific 
amino acid blends. However, ideally the chosen micro-
bial chassis should be modified to increase in  vivo pro-
duction of the required amino acid precursors, enabling 
the required bio-alkane blends to be generated from the 
locally derived waste feedstock.
Successful commercialisation of this approach would 
require the utilisation of cost-effective feedstocks and 
amino acid supply, such as proteinaceous waste (e.g. 
food waste). One study found the amino acid content of 
39 samples of vegetal and dairy product food waste from 
EU industrial agro-food systems had a valine content 
between 6.4 and 29.4  mg/g waste [26]. Therefore, this 
waste could potentially be utilised as both a carbon and 
amino acid source.
Halomonas as industrial chassis
Economically viable scaled bio-production strategies 
can be difficult to achieve due to high capital and oper-
ating expenditures of typical fermentation systems. This 
includes energy intensive running costs such as sterili-
sation, aseptic growth conditions, complex monitoring 
systems and downstream processing. Environmental 
concerns include the use of vast quantities of clean water 
and the route of waste disposal. To address these con-
cerns, CvFAP-dependent bio-LPG production from VFAs 
was recently demonstrated in the halophilic production 
host Halomonas [4]. This microbial chassis grows at high 
salinity (up to 20% w/v NaCl) and pH values (up to 12), 
allowing for cultivation in seawater, waste-water or recy-
cled water without the need for costly sterilisation and 
aseptic conditions [27]. This allows Halomonas bioreac-
tors to be constructed using low cost materials, such as 
plastics, ceramics and cement, with overall costs savings 
of ca 65% compared to conventional scaled E. coli culti-
vation [28].
Given our recent success in transitioning CvFAP-
dependent VFA to propane production from E. coli to 
Halomonas [4], we decided to take a similar approach 
with the KdcA-dependent amino acid pathway. Pre-
liminary IPTG-inducible and constitutively expressed 
KdcA-dependent pathways were introduced into Halo-
monas, using both plasmid-borne and chromosomal 
integration strategies [4]. Bio-propane production was 
successfully demonstrated in small scale in  vivo batch 
cultivation using valine-supplemented medium [4]. 
However, the scalability of the process was not tested, 
and construct optimisation had not been performed for 
expression in Halomonas. To address this, we utilised 
the highest performing E. coli construct  (IHKFG462I) to 
generate six Halomonas-specific plasmids, which dif-
fered only by the promoter system. An efficient IPTG-
inducible MmP1 T7-like promoter (T7L) was initially 
employed [4], as standard pET vector-based viral sys-
tems do not function in Halomonas [29]. Following 
our success in re-purposing trc into two constitutive 
promoters for E. coli (TrΔL and ΔL; Additional file  1: 
Table S5), we performed equivalent truncations in T7L 
to generate constitutive promoters T7LΔL and HΔL, 
respectively. We also tested three variant Halomonas 
promoters (c102, c69 and c59), which are based on 
the major outer membrane protein porin constitutive 
expression system (Additional file 1: Fig. S11; [30, 31]). 
Preliminary studies with the constructs containing T7L 
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and c69 promoters in standard (non-supplemented) 
media were reported elsewhere [4], and form the basis 
of comparison with the remaining four constructs 
under constitutive control in this study.
The best performing construct in Halomonas con-
tained the  CvFAPG462I variant under T7L control, gen-
erating primarily isobutane (9.32 ± 0.63  mg/L; Fig.  4a; 
[4]). This is around fourfold lower than the equiva-
lent E. coli  IHKFG462I system under double trc control 
(38.6 ± 2.5 mg/L isobutane). Titres of propane were also 
decreased around twofold (3.78 ± 0.26 mg/L) in simple 
medium (no amino acid supplementation). For the 
constitutive expression systems, the best performers 
were controlled by T7LΔL and HΔL promoters (Fig. 4a; 
Additional file  1: Table  S5). Surprisingly, titres of gas-
eous alkanes were lower using the Halomonas-specific 
Pporin-like variant constitutive promoters (c59, c69 and 
c102) compared to the truncated T7-like ones. In the 
majority of these constructs, the relative proportion of 
propane was increased relative to isobutane, to near 
equivalent levels.
The top three performers were further investigated 
by determining the increase in propane production in 
the presence of supplemental valine (30  mg/mL). Sur-
prisingly, propane titres of the inducible construct 
only increased twofold (7.99 ± 1.07  mg/L; Fig.  4b; 
Additional file  1: Table  S5), compared to the 17-fold 
increase with comparable constructs in E. coli (Fig. 3b; 
[4]). In each case, the relative concentrations of (iso)
butane in valine-supplemented medium were dramati-
cally decreased compared to standard media (Fig.  4b; 
Additional file  1: Table  S5), likely due to competition 
for CvFAP active site. This suggests a limiting factor in 
this process may be the rate of amino acid uptake and/
or endogenous amino acid metabolism by Halomonas 
compared to E. coli, and may also be contributing to 
the overall lower gaseous alkane titres in Halomonas 
compared to E. coli. Alternatively, one or more of the 
pathway enzymes may be unstable or poorly expressed 
in Halomonas. Notwithstanding, the prototype produc-
tion pathway has been successfully demonstrated in 
Halomonas.
Chromosomal integration into Halomonas
Chromosomal integration of pathways into an industri-
ally robust microbial chassis is preferable to maintaining 
the genes for these pathways on a plasmid, as it elimi-
nates the need for expensive and/or toxic selection agents 
[32], and prolongs the fermentation time to maximise 
product yields. To investigate this, we integrated four 
versions of the  IHKFG462I pathway into Halomonas strain 
TQ10 at two chromosomal loci (nodes 3 and 15; [33]), 
each differing only by the promoter type (T7L, T7LΔL, 
HΔL and c69). This was performed by utilising a novel 
suicide vector protocol (Additional file 1: Fig. S7), which 
was based on previously published methods [4, 34, 35]. 
Small-scale batch cultures were compared for gaseous 
alkane production in the presence and absence of supple-
mental valine (30 mg/mL).
As expected, the highest performing strain contained 
the inducible T7L promoter (1.39 ± 0.09 mg/L isobutane; 
[4]), however similar titres were obtained for the consti-
tutive HΔL system (1.19 ± 0.01  mg/L isobutane; Fig.  4a; 
Additional file 1: Table S5). Overall, combined gas titres 
Fig. 4 Effect of the KdcA-dependent pathway promoter on gaseous 
alkane production in Halomonas TQ10 in the a absence or b presence 
of valine culture supplementation. Pathway promoter-IHTrKFG462I 
was present as either a plasmid-borne or chromosomally integrated 
construct (single site). Cultures (20 mL) were grown in LB medium 
containing 30 µg/mL kanamycin for 4–6 h  (OD600 ~ 0.6–0.8) at 37 °C 
and 180 rpm. Recombinant protein expression was induced with IPTG 
(0.1 mM) and culture supplementation with valine (30 mg/mL) after 
1 h at 30 °C. Triplicate samples (1 mL) each of 3 biological replicate 
cultures were sealed into glass vials (4 mL) and incubated at 30 °C 
for 16–18 h at 200 rpm, illuminated continuously with a blue LED 
(455 nm or 470 nm). Gaseous hydrocarbon levels were determined 
by manual headspace injection using an Agilent 490 Micro GC, 
containing an  Al2O3/KCl column. The errors represent one standard 
deviation of the data
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were significantly lower than for the equivalent plasmid 
systems, as in each case only a single copy was present in 
the genome. However, these differences were less marked 
in the presence of valine supplementation, with the HΔL 
construct showing only about twofold decrease in pro-
pane titres compared to the equivalent plasmid-borne 
system (1.84 ± 0.28 mg/L propane; Fig. 4b).
The chromosomal integration site had a significant 
impact on the overall gas titres, with loci 1 (node 3; [33]) 
showing ca a 2.5-fold increase over loci 2 (node 15; Addi-
tional file 1: Table S5). This suggests there is scope to sig-
nificantly improve bio-gas titres by screening a variety of 
integration sites and/or multi-copy insertion of the con-
struct into the Halomonas chromosome [33].
Fermentative amino acid to bio‑alkane production 
in Halomonas
To investigate the scalability of this fermentative bio-
alkane approach, we performed laboratory-scale cul-
tivations of Halomonas expressing the plasmid-borne 
inducible  IHKFG462I construct (T7L promoter) up to 48 h 
in a flatbed photobioreactor (400 mL). Fermentations in 
standard Halomonas medium (~ 0.25% amino acid blend) 
containing glycerol [4] showed primarily propane pro-
duction, with an estimated 17  mg propane/g cells over 
Fig. 5 Bio-alkane production by Halomonas TQ10 expressing  IHKFG462I in plasmid or chromosomally integrated constructs. Cumulative alkane 
production by the plasmid-borne inducible construct pHT7LIHKFG462I in LB60 medium supplemented with a casamino acids or b valine. Rate 
of alkane production of Halomonas TQ10 expressing chromosomally integrated c N3T7LIHKFG462I (inducible) or d N3cΔLIHKFG462I (constitutive). 
Photobioreactor cultivation (400 mL) was performed with medium pH 6.8 containing 0.5 mL/L antifoam and antibiotic (50 μg/mL spectinomycin 
or 34 μg/mL chloramphenicol for plasmid-borne and constitutive constructs, respectively). The culture was maintained at 30 °C with 60% stirring 
output with an airflow rate of 1.21 L/min, and ambient room lighting until mid-log phase (4–5 h). Protein expression was induced by 0.1 mM 
IPTG, where required, and the culture was maintained for 24–240 h with blue light exposure (1656). Culture medium feeding was employed to 
maintain an optical density of 0.8 and to replenish the carbon source for the chromosomal constructs. Alkane gas production was monitored by 
automated (a, b) or manual (c, d) headspace sampling using a Micro GC. The effect of amino acid supply on gaseous alkane titres was investigated 
by performing triplicate fermentations in three different culture media (Additional file 1: Figs. S8–10). Cumulative propane, isobutane and butane 
titres were calculated from the average production rates per hour in fermentations from freshly transformed Halomonas TQ10 in each media (a, b 
and Additional file 1: Fig. S11)
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48 h (Additional file 1: Fig. S11). The addition of casamino 
acids (~ 2% amino acid blend) led to predominantly 
isobutane production (max 27 mg propane/g cells), with 
propane and butane titres around threefold lower (about 
9 mg propane/g cells; Fig. 5a). This switch in bio-alkane 
gas predominance is consistent with the individual amino 
acid concentrations in each medium (Additional file  1: 
Fig. S12). Valine-supplemented medium (1.8%) saw 
propane titres rise to around 90  mg propane/g cells in 
46  h (Fig.  5b), equivalent to Halomonas TQ10 express-
ing  CvFAPG462V with supplemental butyric acid (89  mg 
propane/g cells; [4]). In most cases, the rate of gaseous 
alkane production peaked within the first 24 h, followed 
by a rapid decline in production (Additional file 1: Figs. 
S8–S10). This is attributed to plasmid instability and/or 
loss, or possibly CvFAP light inactivation [4, 23].
The longevity of the bioprocess was investigated by 
continuous flow fermentation of the genome integrated 
 IHKFG462I Halomonas strains (T7L and HΔL; node 3) 
in valine-supplemented medium. Fermentation of the 
inducible (T7L) strain showed a gradual increase in pro-
pane production, peaking at around 70  h (~ 180  mg/g 
cells/day), followed by a slow decline to minimal titres 
by ~ 140  h (Fig.  5c). This suggests a gradual decrease in 
biocatalytic enzyme production, likely due to degrada-
tion/inactivation of IPTG and/or CvFAP photoinac-
tivation [23] during the extended fermentation time 
[36]. Significant propane production in this strain was 
extended to nearly 5  days, however elimination of the 
need for IPTG could potentially extend propane produc-
tion even further.
The constitutively expressed (HΔL) Halomonas strain 
showed a fairly consistent propane production rate from 
60 to 200  h (up to 30  mg/g cells/day; Fig.  5d), followed 
by a rapid decline in bio-alkane production and cell 
viability. This loss of Halomonas viability is presumably 
due to the extended exposure to high-intensity blue light 
that is required for CvFAP activity. Cytotoxicity of blue 
light is a common feature of microorganisms in general 
[37]. Therefore, process optimisation to reduce the blue 
light intensity is required for efficient photocatalysis by 
CvFAP to extend propane production further. An alter-
native strategy could be employed where periodic ‘dark 
cycles’ are implemented, to allow cultures to regenerate 
to high cell density in the absence of light. For example, 
Halomonas TD01 (precursor of strain TQ10) is known 
to grow to high cell density (40  g/L cells dry weight) in 
24  h with nutrient feeding [27]. This could be followed 
by feeding with amino acids and blue light exposure to 
switch on alkane gas production, until a decline in pro-
ductivity is seen.
Overall, propane production in the constitutive 
strain decreased nearly eightfold from the equivalent 
IPTG-inducible strain. However, stable expression lev-
els over an extended fermentation time could potentially 
generate higher levels of propane overall. Therefore, this 
fermentative approach from amino acids to gaseous 
alkanes could potentially be scaled to produce bio-LPG 
from proteinaceous feedstocks. Process and chassis engi-
neering to increase bio-LPG titres could provide a viable 
alternative approach to the simpler route from VFAs.
Conclusions
The fermentative KdcA-dependent pathway from amino 
acids to gaseous alkanes provides an alternative, yet com-
plementary solution to VFA-dependent bio-LPG produc-
tion. This wholly biological approach is in stark contrast 
to existing commercial ‘bio-LPG’ production strategies 
[38], which are essentially a chemically synthesised prod-
uct from biologically sourced materials. Utilising Halo-
monas as the microbial chassis of choice, cultivated on 
renewable proteinaceous waste, could potentially reduce 
the process costs to enable successful commercialisation. 
Site-specific implementation of direct (VFA) or pathway 
driven (amino acid) strategies would be dependent on 
the availability and relative composition of local waste 
feedstocks, and the economics of waste pre-processing 
(hydrolysis vs anaerobic digestion). These renewable and 
sustainable approaches to clean-burning gaseous fuels 
could reduce the dependence on and environmental 
impact of fossil fuel combustion, and tap into the existing 
global market (US$19.5 billion in 2017) of amino acids.
Materials, services and equipment
All chemicals, solvents and reagents were purchased 
from commercial suppliers, and were of analytical grade 
or better. The gas calibration standard was a custom 
blend of 1% each of propane, butane and isobutane in 
nitrogen (Thames Restek, Saunderton, UK). Media com-
ponents were obtained from Formedium (Norfolk, UK). 
The E. coli strains used for propagating all plasmids were 
Stellar™ (Clontech) or  NEB®5α (New England Biolabs). 
Expression studies were carried out using E. coli strains 
BL21(DE3) and NiCo21(DE3) (New England Biolab). 
E. coli strain BL21(DE3) was modified by chromosomal 
deletion of two aldehyde reductase genes yqhD and yjgB 
(BL21(DE3)∆yqhD/∆yjgB/KanR) [5], and the kanamycin 
selection gene was removed (BL21(DE3)ΔΔ) as described 
previously [4]. Halomonas strain TQ10-MmP1 and mod-
ified pSEVA plasmids have been described previously [4].
Gene sequencing and oligonucleotide synthesis were 
performed by Eurofins MWG (Ebersberg, Germany). 
Details of all the plasmid and chromosomal constructs 
used in this study are found in Additional file  1: Tables 
S5–S7. pSBR1Ks-i-SceI is a hybrid of pSEVA and Bio-
brick (pBb-type) plasmids, containing oriT, I-SceI 
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meganuclease gene under trc control, pRO1600-ColE1 
double origin and both kanamycin and spectinomycin 
resistance markers. Plasmids pSH-N3 and pSH-N15 are 
based on the CRISPR/Cas9 editing Halomonas genome 
donor DNA pSEVA241 plasmid of Quin et al. [35], except 
the gRNA and antibiotic resistances were removed, and 
the insert contained the target DNA with a pKIKO-
derived chloramphenicol resistance gene flanked by FRT 
sequences [39]. Node 3 and node 15 refer to Halomonas 
chromosomal loci for insertion of target DNA [33]. The 
modified pPorin-like constitutive promoter plasmids 
pHc102-RFP, pHc69-RFP and pHc59-RFP were kindly 
supplied by Duangthip Trisrivirat (Vidyasirimedhi Insti-
tute of Science and Technology; VISTEC). These plas-
mids are a modified pHal2-based plasmid [4] containing 
RFP with the T7-like promoter swapped for a modified 
pPorin-like constitutive promoter. The BglBrick series 
of vectors were obtained from Addgene (https ://www.
addge ne.org) [40]. Gene synthesis was performed by 
GeneArt (ThermoFisher, Germany) or GenScript (USA). 
The sequences of all the oligonucleotides used in cloning 
and mutagenesis can be found in Additional file 1: Tables 
S8–S12.
The mounted high-power blue LEDs and LED driv-
ers were from Thorlabs (Ely, U.K.), with spectra centred 
at 470 nm (FWHM 25 nm, 710 mW typical output). The 
custom-built LED blue light array had area of 396  cm2 
of relatively consistent light intensity and a fixed average 
culture-to-LED distance of 8  cm. The photobioreactor 
was a thermostatic flat panel FMT 150 (500  mL; Pho-
ton Systems Instruments, Czech Republic) with integral 
culture monitoring (OD 680/720  nm), pH and feeding 
control and an LED blue light panel (465 nm; maximum 
PPFD = 1648 μE photons).
Single and multi‑gene construct synthesis
The propane synthesis plasmids pTPC7 (YciA-sfp-CAR; 
[6]),  ADOA134F, petF (Ferr) and  pCvFAPG462V (fatty acid 
photodecarboxylase from Chlorella variabilis) were 
assembled as described previously [4, 6]. A second 
IPTG-inducible  CvFAPG462V construct was generated by 
sub cloning the variant gene into pBbA1c-RFP (pTrCv-
FAPG462V), eliminating the RFP gene. The following 
genes were designed, synthesised and sub-cloned into 
pET21b, incorporating a C-terminal  His6-tag: leucine 
2-oxoglutarate transaminase from E. coli (ilvE; UniProt: 
P0AB80); human branched-chain α-keto acid dehydro-
genase (BCKDHAB; P12694 and P21953;  His6-tag on 
subunit B only), phenylacetaldehyde dehydrogenase 17 
from E. coli (PadA; P80668), threonine dehydratase from 
E. coli (ilvA; P04968) and the E. coli leuABCD complex 
composed of 2-isopropylmalate synthase (LeuA; P09151), 
2-isopropylmalate dehydrogenase (LeuB; P30125) and 
isopropyl malate isomerase complex (LeuC/LeuD; 
P0A6A6/P30126). Additional synthesised genes sub-
cloned into pETM11 were α-ketoglutaric semialdehyde 
dehydrogenase from Azospirillum brasilense (αKGSDH; 
Q1JUP4) and 3-hydroxypropionaldehyde dehydroge-
nase from E. coli (Hpad; P23883), while branched-chain 
keto acid decarboxylase from Lactococcus lactis (KdcA; 
Q6QBS4) was sub cloned into pET28b. These latter 
genes contained a vector-derived N-terminal  His6-tag. 
Genes were codon optimised to remove rare codons for 
optimal expression in E. coli. For LeuABCD, the native 
E. coli operon sequence was synthesised (no  His6-tags), 
with gene expression controlled by a single T7 promoter 
(Additional file 1: Table S5).
The multi-gene construct pYSCAP (YciA-sfp-CAR-
ADOA134F-Ferr) contained the genes encoding non-His6-
tagged versions of acyl-CoA thioester hydrolase from 
Haemophilus influenza (YciA; P44886); maturation factor 
phosphopantetheinyl transferase from Bacillus subtilis 
(sfp; P39135); carboxylic acid reductase from Mycobacte-
rium marinum (CAR; B2HN69); aldehyde deformylating 
oxygenase variant A134F from Prochlorococcus marinus 
(ADO; Q7V6D4) and ferredoxin from Synechocystis sp 
PCC6803 (Ferr; P27320) [5, 6]. This construct was syn-
thesised as a complete operon with codon-optimised 
genes, synthetic Shine–Dalgarno (SD) sequences and the 
constitutive promoters R0011 (http://2015.igem.org/) 
and proD upstream of YciA and  ADOA134F, respectively 
[20].
Multi‑gene constructs assembly in E. coli
In most cases, the assembly of multi-gene constructs 
was performed by In-Fusion cloning, according to the 
manufacturer’s protocols [41]. Vector linearisation and 
insert(s) amplification were performed by   polymerase 
chain reaction (PCR), using the CloneAmp™ HiFi PCR 
Premix kit (Clontech), incorporating 15–25 bp overhangs 
necessary for subsequent ligations. In some cases, over-
lap extension PCR (OEP) was performed to ligate two 
or more DNA fragments generated by PCR to simplify 
subsequent construct assembly. In this method an initial 
5 PCR cycles were performed with the template DNA 
fragments only, followed by the addition of the forward 
primer of the first DNA fragment and the reverse primer 
of the last insert. Following In-Fusion cloning, each con-
struct was transformed into the E. coli strain Stellar or 
NEB5α for plasmid recovery, and the correct assembly 
was confirmed by DNA sequencing. The oligonucleotide 
sequences and template DNA used in each PCR reaction 
is shown in Additional file 1: Tables S8–S12. The follow-
ing sections will detail the general approaches taken for 
the assembly of each plasmid.
Page 11 of 15Amer et al. Biotechnol Biofuels          (2020) 13:125  
ADO‑containing CoA‑dependent multi‑gene E. coli constructs 
assembly
A dual construct was assembled in pBbE2k [40] con-
taining  ADOA134F and its electron transfer partner Ferr 
[6], under the control of a tetracycline-inducible pro-
moter. Both  ADOA134F and Ferr genes were PCR ampli-
fied from their respective constructs in pCDFDuet-1 and 
pRSF-Duet1 [6]. The PCR products included the exist-
ing vector-derived 5′-SD sequence for  ADOA134F and a 
non-native SD sequence (GGA GGA CAG CTA A) for Ferr. 
In-Fusion cloning was performed with the linearised des-
tination vector pBbE2k-RFP, minus the RFP gene and its 
SD sequence, to generate pTetADOA134FFerr (Additional 
file 1: Table S8).
The assembly of a butyryl-CoA to propane pathway 
construct pAFYSC (T7-ADOA134F-Ferr-YciA-sfp-CAR) 
was performed using the vector pETDuetT-1. PCR line-
arisation of construct TPC7 (T7-YciA-sfp-CAR) occurred 
between the T7 promoter and the initial SD sequence, 
while the two genes from  pADOA134FFerr were ampli-
fied with both SD sequences. In-Fusion cloning between 
the two PCR products generated the IPTG-inducible 
pAFYSC pathway (Additional file 1: Table S8).
To eliminate the need for IPTG induction, a constitu-
tive expression system was constructed using the Bgl-
Brick plasmid pBbE7k-RFP as the backbone [40]. The 
plasmid was linearised by reverse PCR, eliminating 
the T7 promoter-RFP cassette (lacIq retained), and the 
proD-ADOA134F insert was amplified from the multi-
gene construct pYSCAP. Following In-Fusion cloning, 
the new ADO-containing constitutive expression vector 
(pPrADOA134F) was used as the backbone for the con-
struction of a series of ADO-dependent pathways from 
butyryl-CoA to propane. The first constitutive pathway 
assembled was pPr*AFYSC (proD*-ADOA134F-Ferr-YciA-
sfp-CAR), via the ligation of the pAFYSC pathway genes 
(SD-ADOA134F-Ferr-YciA-sfp-CAR) into the linearised 
proD-containing empty plasmid (pPrADOA134F minus 
SD-ADOA134F; Additional file 1: Table S8). This was fol-
lowed by linearisation of pPr*AFYSC by reverse PCR to 
eliminate the now redundant  lacIq repressor. The new 
construct (pPrAFYSC) was re-circularised by In-Fusion 
cloning in the absence of any insert.
The generation of ADO-dependent pathways to pro-
pane, butane and isobutane from the amino acids valine, 
isoleucine and leucine, respectively, requires the addi-
tion of genes ilvE and BCKDHAB to the existing AFYSC 
constructs (Fig.  1). Initially a constitutively controlled 
dual enzyme construct (pPr*IB; proD*-ilvE-BCKDHAB) 
was assembled in the same modified BioBrick plasmid as 
used for pPr*AFYSC construction. The individual genes 
(ilvE and BCKDHAB) were amplified by PCR from their 
respective synthesised constructs. This was followed by 
OEP to generate a dual enzyme insert, followed by liga-
tion to the linearised empty vector (pPr*AFYSC minus 
AFYSC). A complete pathway from amino acid to gas-
eous hydrocarbon was generated by the inclusion of 
ilvE-BCKDHAB with AFYSC to form pPr*AFYSCIB 
(proD*-ADOA134F-Ferr-YciA-sfp-CAR-ilvE-BCKD-
HAB). This was performed by linearising pPrAFYSC 
after CAR, and ligating it to the ilvE-BCKDHAB insert 
amplified from pPr*IB. To increase the expression of ilvE 
and BCKDHAB, a second proD promoter was inserted 
downstream of CAR in pPrAFYSC by In-Fusion cloning, 
to generate pPrAFYSCPr (Additional file  1: Table  S8). 
Insertion of the ilvE-BCKDHAB fragment of pPr*IB after 
the second proD generated pPr*AFYSCPrIB (proD*-
ADOA134F-Ferr-YciA-sfp-CAR-proD-ilvE-BCKDHAB.
IPTG-inducible constructs catalysing gaseous hydro-
carbon production from amino acids were generated by 
amplifying the seven pathway genes from pPr*AFYSCIB 
and ligating them into pBbE1k, linearised downstream of 
the trc promoter (pTrAFYSCIB; trc-ADOA134F-Ferr-YciA-
sfp-CAR-ilvE-BCKDHAB). Similarly, the addition of a 
second trc promoter upstream of ilvE was performed by 
PCR coupled to In-Fusion cloning to generate pTrAFY-
SCTrIB (trc-ADOA134F-Ferr-YciA-sfp-CAR-trc-ilvE-BCK-
DHAB; Additional file 1: Table S8).
FAP‑containing CoA‑dependent multi‑gene E. coli constructs 
assembly
Simplified gaseous hydrocarbon producing constructs 
from amino acids were generated by substituting the 
four genes CAR, sfp,  ADOA134F and Ferr for a single gene 
CvFAP variant G462V or G462I. An initial construct 
pTrFG462VYIB was generated (trc-CvFAPG462V-YciA-
ilvE-BCKDHAB) using pTrAFYSCIB as the backbone. 
This latter plasmid was linearised, eliminating the genes 
encoding AFYSC (Additional file  1: Table  S9). A dual 
gene insert was constructed  (CvFAPG462V-YciA) by PCR 
amplification of each individual gene, followed by OEP. 
This was ligated to the backbone plasmid upstream of 
ilvE, generating an IPTG-inducible construct. A similar 
constitutive construct pPrFG462VYIB (proD-CvFAPG462V-
YciA-ilvE-BCKDHAB) was generated as above, except 
the backbone template was the proD-containing plasmid 
pPrAFYSCIB.
KdcA‑dependent multi‑gene E. coli constructs assembly
Alternative  CvFAPG462V-dependent pathways were con-
structed by the substitution of six genes (BCKDHAB, 
YciA, CAR, sfp,  ADOA134F and Ferr) for KdcA, an alco-
hol dehydrogenase and  CvFAPG462V. These pathways 
were constructed in pBbE1k, including the insertion of 
a second trc promoter upstream of the latter two genes 
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(trc-KdcA-CvFAPG462V). Each individual gene and sec-
ond trc promoter were amplified by PCR, and OEP was 
performed between trc and KdcA DNA fragments (Addi-
tional file 1: Table S10). In-Fusion cloning was performed 
generating three KdcA-dependent and IPTG-inducible 
constructs (pTrIA*TrKFG462V, where A* = αKGSDH, 
PadA or Hpad; Additional file 1: Table S5). Each of these 
three constructs underwent site-directed mutagenesis of 
the CvFAP gene to produce the equivalent pathway with 
the variant G462I (pTrIαKTrKFG462I, pTrIΠTrKFG462I and 
pTrIΗTrKFG462I, respectively) as described previously [4].
Halomonas KdcA‑dependent construct assembly
Six KdcA-dependent pathways were constructed in the 
Halomonas-compatible plasmid pHal2 [4], which var-
ied by the type of promoter used. This was performed 
by multi-step In-Fusion cloning, where PCR was used 
to amplify the inserts, eliminating the  His6-tags, and/
or linearise the vectors (Additional file  1: Table  S11). 
Each construct was propagated in the E. coli conjuga-
tive donor strain S17-1 [42]. Plasmid transformation into 
Halomonas was performed by conjugation according to 
the method described previously [4]. Plasmid content of 
each trans-conjugant was confirmed by DNA isolation, 
restriction mapping and sequencing.
The initial construct was generated under control of 
the IPTG-inducible MmP1 T7-like promoter (pHT7LI-
HKFG462I; [4]), which later underwent  LacIq elimination 
(T7LΔL) to generate the respective constitutive construct 
(pHT7LΔLIHKFG462I). A second constitutively expressed 
construct was generated by substituting the T7-like pro-
moter for a truncated trc promoter, which was deficient 
in both trc and lacI (pHΔLIHKFG462I). Three constitu-
tive promoters were generated (c102, c69 and c59) based 
on the major outer membrane protein porin constitu-
tive expression system in Halomonas (Additional file  1: 
Fig. S11; [30, 31]). The  IHKFG462I operon was inserted 
downstream of each promoter, generating a further three 
Halomonas constructs (pHc102IHKFG462I, pHc69IHK-
FG462I and pHc59IHKFG462I).
Chromosomal integration of pathway genes 
into Halomonas
Chromosomal insertion of the KdcA-dependent path-
ways into Halomonas TQ10 was performed using a novel 
suicide vector (pSH) protocol (Additional file 1: Fig. S7) 
based on previously published methods [4, 34, 35]. The 
pSH insertion plasmids (pSH-N3 and pSH-N15) con-
tained the biocatalytic and pKIKO-derived FRT flanked 
[39] chloramphenicol resistance genes surrounded by 
homology arms (node 3 or 15; [33]), an I-SceI restric-
tion site and a colE1 ori (incompatible) with replication 
in Halomonas (Additional file  1: Fig. S10 inset). This 
plasmid was co-conjugated into Halomonas TQ10-
MmP1 with a second spectinomycin-resistant plasmid 
(pSBR1Ks-i-SceI), the latter expressing the restriction 
enzyme I-SceI. In vivo expression of I-SceI linearised pSH 
plasmids facilitates chromosomal integration [34, 35]. 
Successful integration was seen as growth of Halomonas 
on chloramphenicol-selective medium, as the pSH plas-
mid is not replicated in Halomonas. Integration was con-
firmed by colony PCR, genomic sequencing and in vivo 
propane production after pSceI plasmid curing [34, 35].
Eight KdcA-dependent constructs (ilvE-Hpad-kdcA-
CvFAPG462I) were integrated into Halomonas strain 
TQ10 (Additional file  1: Table  S12). The constructs 
varied by the chromosomal loci (node 3 or 15) and the 
promoter type (inducible vs constitutive). The inducible 
system was the MmP1 T7-like promoter (T7L), while the 
constitutively expressed constructs were controlled by 
pPorin-like 69 (c69),  lacIq-deficient MmP1 T7-like pro-
moter (T7LΔL) or the truncated pTrc promoter minus trc 
and lacI (ΔL; Additional file 1: Table S12). The insertion 
of inducible T7LIHKFG462I or constitutive c69IHKFG462I 
constructs into pSH-N3 or pSH-N15 was performed via 
In-Fusion cloning using PCR linearised destination vec-
tors (between one homology arm and upstream of the 
chloramphenicol gene; Additional file  1: Fig. S5) and 
amplified multi-gene constructs with their own promot-
ers (N3- or N15T7LIHKFG462I; N3- or N15c69IHKFG462I). 
For the ΔL-containing plasmids, a similar protocol was 
performed as above, except the T7LIHKFG462I con-
struct for each node was used as the template, and the 
only DNA eliminated/inserted was the promoter (N3- or 
N15cΔLIHKFG462I). To generate the constructs with the 
T7LΔL promoter, PCR elimination of the laciq gene was 
performed on the equivalent T7L-containing constructs 
followed by self In-Fusion cloning to re-circularise the 
plasmid (N3- or N15cT7LΔLIHKFG462I). Successful inte-
gration of the constructs at the correct loci was con-
firmed by colony PCR and genome sequencing.
Protein expression and lysate production
IPTG-dependent expression of proteins YciA, CAR, 
sfp,  CvFAPG462V,  ADOA134F and Ferr in E. coli has been 
demonstrated previously [4, 6]. The remaining pro-
teins ilvE, BCKDHAB, KdcA, αKGSDH, PadA, Hpad 
ilvA and LeuABCD were transformed into E. coli strain 
BL21(DE3) for protein overexpression studies. Cultures 
(1 L) were grown in LB Broth Miller (Formedium) con-
taining the required antibiotic (50  μg/mL ampicillin 
or 30  μg/mL kanamycin) at 37  °C with 180  rpm shak-
ing until  OD600nm = 0.6. Recombinant protein induc-
tion was performed with IPTG (0.1  mM), followed by 
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a further 12–16 h incubation at 25  °C. Cells were har-
vested by centrifugation at 3320×g for 30 min at 4 °C.
Cells were resuspended in lysis buffer (5  mL/g pel-
let; 50 mM Tris pH 7.0 containing 1 mM  MgCl2, 1 mM 
β-mercaptoethanol, 10% glycerol, 2X protease inhibi-
tors, 50  μg/mL DNAse and 50  μg/mL lysozyme) and 
freeze-thawed in liquid nitrogen. Cells were lysed 
by sonication, and clarified using centrifugation 
(48,000×g). Protein content was determined using 12% 
SDS-PAGE gels (Mini-Protean TGX Stain-Free Pre-
cast Gels, Bio-Rad). Protein gels were imaged using a 
BioRad Gel Doc EZ Imager and relative protein band 
intensity was determined using the BioRad ImageLab 
software. Identification of  His6-tagged proteins was 
performed by Western blots using the Trans-Blot® 
Turbo™ Transfer system (PVDF membranes; BioRad) 
and the Western Breeze Chemiluminescent Immuno-
detection kit (alkaline phosphatase; Life Technologies) 
with mouse (His tag monoclonal antibody) and alkaline 
phosphatase-containing (Anti-C-My) primary and sec-
ondary antibodies, respectively.
Gaseous hydrocarbon production
In vivo gaseous hydrocarbon production by recom-
binant E. coli was performed using the following gen-
eral protocol: cultures (10  mL) were incubated for 
4–6  h  (OD600 ~ 1.6–2) at 37  °C and 180  rpm in LB or 
TB medium containing 50 µg/mL ampicillin, 30 µg/mL 
kanamycin or 50  µg/mL chloramphenicol, dependent 
on the antibiotic resistance (Additional file 1: Table S5). 
Supplemental valine, leucine or isoleucine (up to 
30 mg/L) were included in the medium where required. 
Protein induction (0.1  mM IPTG) was performed for 
trc or T7-containing constructs, and triplicate sam-
ples (1 mL) each of 3 biological replicate cultures were 
sealed into glass vials (3 mL) and incubated at 30 °C for 
16–18  h at 200  rpm, illuminated continuously with a 
blue LED (455 nm or 470 nm).
For propane production in Halomonas, LB60 medium 
(1% tryptone, 0.5% yeast extract, 6% NaCl) pH 9.0 was 
used containing spectinomycin (50  μg/mL). Cultures 
were agitated (180  rpm) at 37  °C for 5  h incubation 
(OD ~ 1.6–2) prior to induction. IPTG (0.1  mM) was 
added (where necessary), and the remaining meth-
odology was performed as described above for E. coli 
cultures.
Photobioreactor cultivation
General photobioreactor cultivation (400  mL) was per-
formed with high salt glycerol medium (30–32% seawa-
ter or Instant Ocean, NaCl to 6%, 0.1% glycerol and 0.5% 
yeast extract) pH 6.8 containing 0.5 mL/L antifoam and 
antibiotic (50  μg/mL spectinomycin or 34  μg/mL chlo-
ramphenicol for plasmid-borne and constitutive con-
structs, respectively). Alternative growth media were 
based on LB60 pH 6.8, which were supplemented with 
1.5% valine (LB60Val) or casamino acids (LB60Cas). Cul-
tivation was performed in batch mode, pre-equilibrated 
at 30  °C with 60% stirring output. An overnight starter 
culture (10–15  mL) of Halomonas TQ10 expressing 
pHT7LIHKFG462I was added, to achieve a starting OD680 
nm of ~ 0.2, and the culture was maintained at 30  °C 
with an airflow rate of 1.21 L/min, automated pH main-
tenance, culture optical density monitoring and ambient 
room lighting until mid-log phase (4–5 h). Protein induc-
tion by IPTG (0.1 mM) was performed for T7L-promoter 
systems with continual monitoring for 2–10  days with 
blue light exposure (1656 or 600 μE for plasmid-borne 
and chromosomal systems, respectively). Alkane gas pro-
duction was monitored at 20-min intervals by automated 
headspace sampling using a Micro GC, while aqueous 
amino acid and glycerol depletion were quantified by 
HPLC.
Fermentations of Halomonas TQ10 contain-
ing chromosomally integrated N3T7LIHKFG462I or 
N3cΔLIHKFG462I was performed as above with LB60Val 
pH 6.8, except culture medium feeding was employed to 
maintain an optical density of 0.8 and to replenish the 
carbon source. Cultures were maintained for about 240 h, 
with alkane gas production monitored at 2–3 times daily 
by manual sampling using a Micro GC.
Analytical techniques
Propane levels were determined by manual headspace 
injection or automated (fermentation off gas moni-
toring) using an Agilent 490 Micro GC, containing an 
 Al2O3/KCl column and a thermal conductivity detec-
tor (TCD). Aqueous culture metabolites (VFAs and 
glycerol) were analysed by HPLC using an Agilent 1260 
Infinity HPLC with a 1260 ALS autosampler, TCC SL 
column heater, a 1260 refractive index detector (RID) 
with an Agilent Hi-Plex H column (300 × 7.7  mm; 
5  mM  H2SO4). The running conditions for both the 
Micro GC and HPLC were the same as described pre-
viously [4]. For amino acid quantitation, analysis was 
performed according to the method of Bartolomeo 
and Maisano [43]. Each analyte concentration was 
calculated by comparing the peak areas to a standard 
curve generated under the same running conditions. 
Error bars indicate one standard deviation of the data 
obtained for the replicates (biological and/or technical 
triplicates).
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